摘要
背景:与其他疾病相比,心血管疾病(CVD)的全球死亡率最高。 与CVD相关的主要危险因素是高血压。 目前的抗高血压(AHT)疗法的主要类型包括血管紧张素转换酶抑制剂(ACEI),血管紧张素受体阻断剂(ARB)和钙通道阻滞剂(CCBs)。 所有这些抗高血压治疗药物具有低口服生物利用度,并且可以诱导上呼吸道抽取,血管性水肿,反射性心动过速和口服后极度的降血压作用,这可引起心脏病患者的致死作用。 目的:通过使用抗高血压药物进行控制和靶向释放可以提供更好的解决方案,克服上述副作用。 结果:开发基于生物聚合物的纳米载体系统的科学进化为安全和/或可食用的纳米药物递送系统开辟了新的视野。在本文中,我们详细回顾了AHT药物的各种机制,与目前的治疗策略相关的主要吸引力,以及AHT纳米药物与常规药物相比的优势。此外,最近有关具有不同AHT药物的生物基纳米/微载体系统的报告已经被分析了其主要特征。壳聚糖作为AHT药物的潜在携带者,由于其独特的性质,包括粘膜粘附性,渗透性以及其生物相容性和生物可降解性,已作深入回顾。 结论:基于壳聚糖的新型AHT纳米凝胶可以通过其在GIT下部的持续释放来改善口服生物利用度,降低疏水性并增加AHT药物的血浆半衰期。
关键词: 纳米载体系统,高血压,抗高血压治疗,壳聚糖纳米颗粒,ACE抑制剂,药物递送。
Current Drug Targets
Title:Prospectives of Antihypertensive Nano-ceuticals as Alternative Therapeutics
Volume: 18 Issue: 11
关键词: 纳米载体系统,高血压,抗高血压治疗,壳聚糖纳米颗粒,ACE抑制剂,药物递送。
摘要: Background: Global death rate due to cardiovascular diseases (CVDs) is highest as compared to other ailments. Principal risk factor associated with CVDs is hypertension. Major classes of current antihypertensive (AHT) therapies include angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs). All these antihypertensive therapeutic drugs have low oral bioavailability and can induce upper respiratory tract abstraction, angioedema, reflex tachycardia and extreme hypotensive effect after oral administration which can cause lethal effects in patients with heart diseases.
Objective: Controlled and targeted release by using antihypertensive nano-medicines can provide better solution to overcome above-mentioned side effects. Results: Scientific evolution towards the development of biopolymer based nano-carrier systems has unlocked new horizons for safe and/or edible nano drug delivery systems. In this article, we have reviewed in detail various mechanisms of AHT drugs, major draw backs associated with current therapeutic strategies, and the advantages of AHT nano-medicines over conventional drugs. Furthermore, recent reports of bio-based nano/micro -carrier systems with different AHT drugs have been analyzed with their key features. In depth review has been presented for chitosan as a potential carrier of AHT drugs due to its distinctive properties comprising muco-adhesive attribute, permeation enhancement as well as its biocompatible and biodegradable nature. Conclusion: Chitosan based novel AHT nano-ceuticals can improve oral bioavailability, reduce hydrophobicity and increase the plasma half-life of AHT drugs by their sustained release in lower part of the GIT.Export Options
About this article
Cite this article as:
Prospectives of Antihypertensive Nano-ceuticals as Alternative Therapeutics, Current Drug Targets 2017; 18 (11) . https://dx.doi.org/10.2174/1389450117666160711163119
DOI https://dx.doi.org/10.2174/1389450117666160711163119 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Associations between Adiponectin Gene Variability, Proinflammatory and Angiogenetic Markers: Implications for Microvascular Disease Development in Type 2 Diabetes Mellitus?
Current Vascular Pharmacology Early Vascular Ageing (EVA): Definitions and Clinical Applicability
Current Hypertension Reviews Recent Development and Future Prospects of Plant-Based Vaccines
Current Drug Metabolism Homeostasis and Compensatory Homeostasis: Bridging Western Medicine and Traditional Chinese Medicine
Current Cardiology Reviews There is no Failure, Only Discovery—the Year Ahead for CARving New Paths
Current Alzheimer Research microRNA in Chondrogenesis, Cartilage and Osteoarthritis
Current Rheumatology Reviews Helicobacter pylori: An Overview on Antimicrobials and Drug Delivery Systems for its Eradication
Current Drug Delivery Statistical monitoring-based alarming systems in modeling the AIDS epidemic in the United States, 1985-2011
Current HIV Research Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
Current Pharmaceutical Design Innate Immunity, Toll-Like Receptors, and Diabetes
Current Immunology Reviews (Discontinued) Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease
Current Pharmaceutical Design Mechanisms of Chondrocyte Survival and Matrix Synthesis During Hypoxia
Current Rheumatology Reviews Anti-Inflammatory Therapeutic Approaches to Reduce Acute Atherosclerotic Complications
Current Pharmaceutical Biotechnology Endothelial Dysfunction and Coronary Artery Spasm
Current Drug Targets - Cardiovascular & Hematological Disorders Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone
Current Drug Safety Potential Interactions of Carotenoids with Other Bioactive Food Components in the Prevention of Chronic Diseases
Current Bioactive Compounds Epidemiological and Maternal Features of Maternal Mortality in the West of Iran: Hamadan, 2011-2019
Current Women`s Health Reviews Deep Inspiration Breath-hold (DIBH) Technique to Reduce Cardiac Radiation Dose in the Management of Breast Cancer
Current Cancer Therapy Reviews Polyphenols: A Diverse Class of Multi-Target Anti-HIV-1 Agents
Current Drug Metabolism Functions of S100 Proteins
Current Molecular Medicine